Dr. Norman M. Ramirez, MD

Dr. Ramirez practices at Rio Grande Regional Hospital in Mcallen, Texas, part of HCA Healthcare.

Dr. Ramirez's NPI, 1871532531, was assigned on June 6, 2006. Dr. Ramirez graduated from Stanford University School Of Medicine in 1981. Dr. Ramirez holds Texas license G1521.

Dr. Ramirez's primary practice is Rio Grande Regional Hospital, at 101 E Ridge Rd, Mcallen, TX 78503 in Hidalgo County. The practice phone is (956) 632-6000.

Dr. Ramirez's primary practice is Rio Grande Regional Hospital in Mcallen, Texas, part of HCA Healthcare. Dr. Ramirez is also affiliated with CHRISTUS Spohn Hospital Corpus Christi - Shoreline. The medical group on file is Rio Grande Cardiovascular and Structural Heart. Dmand AI also links Dr. Ramirez to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramirez practices, 4 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ramirez's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ramirez is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Ramirez's licenses on file in 4 states: Texas, Arizona, Minnesota and North Carolina.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, chronic hypertension, endocarditis, heart device and aorta surgery, heart valve disorders and heart valve surgery among the conditions Dr. Ramirez treats.

CMS data shows 243 Medicare services from Dr. Ramirez across 8 procedure codes in 2024, for 70 Medicare patients. Medicare paid $29,399 for them.

CMS counts 70 Medicare patients who saw Dr. Ramirez in 2024. The largest group is 75 to 84, with 33 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramirez's median patient age at 77, with 47% women.

In 2024, Dr. Ramirez wrote 136 Medicare Part D claims for 90 patients. 99% of them were for generic drugs. CMS names the drug for 116 of them, across 2 drugs with 11 or more claims each, at $1,548 in total drug cost. In 2023, CMS named 105 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Ramirez for performance year 2024, reported as part of a group. Dr. Ramirez accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Ramirez, published from 2015 to 2021. The most frequent topics are Scoliosis and Tomography, X-Ray Computed. Dr. Ramirez has published most often in J Pediatr Orthop. Dr. Ramirez's most frequent co-authors are Norman Ramirez, MD, Claude Shreve Burton, MD and John Flynn, MD.

CMS Open Payments shows 218 general payments to Dr. Ramirez from 18 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 56% of the total. Abbott Laboratories paid the most, $10,622.

Dmand AI lists 1 award for Dr. Ramirez.

Dr. Ramirez graduated from Stanford University School Of Medicine in 1981. Dr. Ramirez is a member of ACC.

Dr. Ramirez is in network with 22 carriers, including Elevance, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.